Introduction
============

Rab GTPases are essential for eukaryotic intracellular membrane and protein trafficking ([@B136]). Specifically, Rab proteins regulate vesicle transport along microtubules and actin filaments ([@B98]; [@B43]), membrane tethering and docking ([@B117]; [@B71]), and SNARE complex formation and membrane fusion ([@B104]). Rabs associate with membranes via hydrophobic isoprenyl groups covalently attached at carboxy-terminal cysteines ([@B16]). Rab GTPases then act by binding to downstream effector proteins and protein complexes ([@B36]).

Nucleotide binding regulates Rab-effector interactions (**Figure [1](#F1){ref-type="fig"}**; [@B117]; [@B36]). Effectors bind specifically to GTP-bound Rab proteins, and therefore the GTP-bound form can be considered the "active" state ([@B36]). GDP-bound Rabs do not bind effectors and can be regarded as "inactive" ([@B36]). Thus, to understand how Rab GTPases function in their cellular context, we must understand how the cell modulates Rab-nucleotide binding.

![GTPase cycle of nucleotide hydrolysis and exchange. GEF, guanine nucleotide exchange factor; GAP, GTPase activating protein.](fcell-06-00129-g001){#F1}

Accessory proteins control Rab GTPase nucleotide binding (**Figure [1](#F1){ref-type="fig"}**; [@B7]). Guanine nucleotide exchange factors (GEFs) activate Rabs by stimulating exchange of bound GDP for GTP ([@B44]; [@B73]). GTPase activating proteins (GAPs) inactivate Rab proteins by boosting their activity for GTP hydrolysis ([@B30]).

This review will discuss how nucleotide binding by Rab7 and its yeast homolog, Ypt7p, is regulated. Rab7 and Ypt7p govern membrane trafficking in the late endocytic and autophagic pathways ([@B122]; [@B38]; [@B57]; [@B37]). The specific processes controlled by Rab7 and Ypt7p are diverse, as reflected by the large and diverse set of Rab7/Ypt7p effectors.

The retromer complex is a Rab7 effector that regulates protein sorting in the endocytic pathway ([@B91]; [@B100]). Retromer directs cargo transport from endosomes to the *trans-*Golgi network (TGN) and plasma membrane ([@B67]). Specifically, retromer mediates retrieval of cargo receptors needed for lysosomal enzyme localization, for example the cation-independent mannose 6-phosphate receptor (CI-MPR), to the TGN ([@B3]). Retromer also mediates trafficking of endocytosed proteins, e.g., the β2-adrenergic receptor (β2AR) and the type II TGF-β receptor (TβRII), from early endosomes to the plasma membrane ([@B112]; [@B132]). Retromer binds the Rab7 GAP TBC1D5 ([@B100]), and this interaction will be discussed in more detail below.

Rab7 also regulates organelle positioning via its effectors Rab7-interacting lysosomal protein (RILP) ([@B17]; [@B53]) and FYVE and coiled-coil containing protein (FYCO1) ([@B80]). RILP recruits the dynein-dynactin motor complex to membranes by binding the p150^Glued^ protein, a subunit of dynactin ([@B53]; [@B52]). Rab7 thereby promotes minus end-directed transport of late endosomes and lysosomes on microtubules, that is, transport away from the cell periphery and toward the nucleus ([@B53]; [@B52]). FYCO1 binds the autophagosomal proteins LC3A and LC3B ([@B77]) and is required for plus end-directed transport, i.e., toward the cell periphery, of autophagosomes on microtubules ([@B80]). FYCO1 also is found on late endosomes and lysosomes, and regulates plus end-directed transport of these organelles as well ([@B80]). The precise mechanism by which FYCO1 regulates organelle positioning remains unknown, but it has been proposed to interact directly or indirectly with kinesin ([@B80]).

Rab7 effectors also regulate protein and lipid kinases that are important for autophagy and for endolysosomal trafficking. Ivy1p, the yeast homolog of the metazoan missing in metastasis (MIM) protein, is a Ypt7p effector ([@B64]) that also interacts with the Ragulator complex ([@B76]), which in turn regulates the target of rapamycin complex 1 (TORC1) in response to cellular amino acid levels ([@B48]). Ivy1p promotes TORC1 activity ([@B76]), suggesting that Ivy1p plays a role in signal transduction in response to metabolic state ([@B48]). Rubicon, a subunit of the endosomal Vps34/class III phosphatidylinositol 3-kinase (PI3KC3) complex, is also a Rab7 effector ([@B108]). Rubicon negatively regulates Vps34 PI-3-kinase activity ([@B137]) and opposes maturation of both autophagosomes ([@B70]) and endosomes ([@B108]).

Finally, Rab7 and Ypt7p mediate membrane tethering and fusion. In yeast, the Ypt7p effector responsible for these activities is the homotypic fusion and protein sorting (HOPS)/vacuole protein sorting class C (Vps class C) complex, usually referred to as HOPS ([@B99]; [@B125]). HOPS is required for membrane tethering ([@B106]) and fusion of lysosomes/vacuoles with late endosomes and autophagosomes ([@B88]; [@B50]; [@B109]). In yeast, HOPS also is needed for homotypic vacuole fusion ([@B99]). There is little evidence that HOPS binds Rab7 in metazoans, where HOPS-membrane recruitment appears to be mediated by Arl8b, an Arf-like GTPase ([@B32]; [@B56]). Instead, human Rab7 directly tethers membranes via formation of a Rab7-Rab7 homodimer ([@B110]).

The following discussion will cover three topics: first, the GEF that activate Rab7/Ypt7p; second, the GAPs that inactivate Rab7/Ypt7p; and third, bacterial effectors, or virulence factors, that modulate Rab7 nucleotide binding to promote intracellular survival and pathogenesis.

Rab7 Gef: the Mon1-Ccz1 Complex
===============================

The Mon1-Ccz1 complex is the GEF for Rab7 in metazoans and yeast ([@B59]; [@B75]; [@B84]). The yeast HOPS subunit Vps39p has been proposed as a Ypt7p GEF ([@B125]), but purified yeast HOPS has no GEF activity toward Ypt7p ([@B75]). Mon1-Ccz1 is a heterodimer ([@B119]). Its subunits were identified in yeast via screens for genes whose deletion causes hypersensitivity to the ionophore monensin (Mon1) ([@B74]) or to high levels of calcium, caffeine, and zinc (Ccz1) ([@B61]). Mon1-Ccz1 localizes to late endosomes, autophagosomes, and the cytosol (**Figure [2](#F2){ref-type="fig"}**; [@B119]; [@B84]; [@B42]; [@B31]). In yeast, Mon1-Ccz1 is present on vacuoles ([@B63]). Mon1-Ccz1 also is found on phagosomes that degrade apoptotic cells ([@B59]).

![Cellular localizations of Rab GEF and GAPs. Green/blue, Monl-Cczl; yellow, Armus/TBC1D2A; pink, TBC1D5; orange, TBC1D15. MVB, multi-vesicular body; ER, endoplasmic reticulum. Black arrows denote trafficking pathways and represent both vesicular and compartment maturation mechanisms. ^∗^Monl-Cczl has a substantial cytosolic localization, particularly when it is phosphorylated ([@B63]). Not shown, Monl-Cczl also localizes to phagosomes.](fcell-06-00129-g002){#F2}

Biochemical Mechanism
---------------------

Mon1-Ccz1 acts by disrupting the nucleotide binding site of Rab7/Ypt7p ([@B60]). **Figure [3](#F3){ref-type="fig"}** depicts a complex of nucleotide-free Rab7 with Mon1-Ccz1, i.e., a stabilized transition state between GDP- and GTP-bound Rab7 ([@B60]). **Figure [3](#F3){ref-type="fig"}** shows a homology model of human Rab7/Mon1-Ccz1 ([@B120]) and is based on the structure of the equivalent proteins from the thermophilic filamentous fungus *Chaetomium theromophilum* ([@B60]).

![Mechanism of nucleotide exchange catalyzed by the Rab7 GEF Monl-Cczl. Purple, nucleotide-free Rab7; green, Monl; blue, Cczl; orange, Rab7-GDP. The Rab7/Monl-Cczl complex shown here is a homology model, built using Swiss-Model and based on the crystal structure of Chaetomium thermophilum Ypt7 bound to C. thermophilum Monl-Cczl (PDB code 5LDD). The black dashed lines only show the connectivity of the switch I and II regions of Rab7-GDP (PDB code 1KY3). The position of the GDP is also taken from PDB code 1KY3. Figure was made using MacPyMOL.](fcell-06-00129-g003){#F3}

Mon1-Ccz1 disrupts GDP binding in two ways. First, the "switch I" region of Rab7 (**Figure [3](#F3){ref-type="fig"}**, purple), which is disordered in Rab7-GDP (**Figure [3](#F3){ref-type="fig"}**, orange/black dashed lines), binds to a hydrophobic cleft in Mon1-Ccz1 (**Figure [3](#F3){ref-type="fig"}**, green and blue, respectively). This causes a lysine sidechain from Rab7 to point inward toward the spot where a Mg^2+^ ion is present in Rab7-GDP (**Figure [3](#F3){ref-type="fig"}**, gray sphere and residue K38; [@B86]). This lysine presumably disrupts Mg^2+^ binding by charge-charge repulsion. Bound Mg^2+^ is essential for nucleotide binding in small GTPases ([@B39]; [@B13]). Thus, loss of Mg^2^*^+^* is proposed to reduce Rab7's affinity for GDP ([@B60]). Second, binding of switch I to Mon1-Ccz1 moves a phenylalanine sidechain in Rab7 away from the area where the guanine ring is found in Rab7-GDP (**Figure [3](#F3){ref-type="fig"}**, residue F33). This phenylalanine makes a stabilizing edge-face aromatic interaction with the guanine in Rab7-GDP ([@B86]). Thus, loss of this interaction should also reduce Rab7 affinity for GDP.

The mechanism of action of Mon1-Ccz1 is quite different from that of other Rab GEFs ([@B44]; [@B73]). Mon1-Ccz1 does not belong to the largest and most well-known class of Rab GEFs, the differentially expressed in normal and neoplastic cells (DENN) domain proteins ([@B44]). Rather, the core element in both Mon1 and Ccz1 is a "longin" domain ([@B14]), a small α-β-α sandwich often found in proteins that regulate intracellular traffic ([@B24]). Longin domains are versatile: some longin domains mediate nucleotide exchange on Rab GTPases, for example as part of the TRAPP complexes ([@B58]; [@B15]), whereas others are found in SNARE proteins and appear to have no GEF activity ([@B92]).

Cellular Role of Mon1-Ccz1
--------------------------

Mon1-Ccz1 is not only a Rab7 GEF, but also a Rab5 effector ([@B59]). Rab5 binding to Mon1-Ccz1 initiates "Rab conversion" on endosomes (**Figure [4](#F4){ref-type="fig"}**; [@B89]). Here, active Rab5 recruits Mon1-Ccz1 to early endosomes ([@B59]). Mon1-Ccz1 also binds to PI(3)P ([@B84]), which is enriched on early endosomes ([@B34]). Mon1-Ccz1 then catalyzes nucleotide exchange on Rab7-GDP, which is extracted from membranes and held in a soluble, cytosolic state by the GDP dissociation inhibitor (GDI) ([@B2]; [@B33]). GDI interacts only with GDP-bound Rab proteins ([@B2]; [@B33]). Thus, nucleotide exchange triggers Rab7-GTP membrane association ([@B84]). A GDI displacement factor (GDF) may facilitate Mon1-Ccz1 activity by disrupting Rab7-GDI binding ([@B25]). Mon1-Ccz1 also displaces the GEF for Rab5, Rabex-5, from membranes ([@B84]). This reduces active Rab5 levels near Rab7-GTP. As a result of these recruitment and displacement actions, active Rab7 replaces active Rab5, thereby converting an early endosome to a late endosome. Rab7 continues this maturation process by recruiting its own effectors ([@B99]; [@B125]; [@B17]; [@B53]; [@B64]; [@B80]; [@B108]).

![Rab conversion from Rab5 to Rab7. Red, Rab5; blue/green, Monl-Cczl; pink, Rabex-5; purple, Rab7; yellow, GDI. Yck3p, yeast vacuolar casein kinase; MTM, myotubularin PI-3 phosphatase. Not shown, a GDF (GDI displacement factor) may disrupt the Rab7-GDI complex ([@B25]).](fcell-06-00129-g004){#F4}

Recruitment of a Rab5 GAP by Rab7 could, in principle, also promote Rab conversion. Such a feedback loop has been observed in the secretory pathway in yeast. Here, the Golgi-localized Rab, Ypt32p, binds a GAP for an ER-resident Rab, Ypt1p ([@B90]). Membrane recruitment of this GAP promotes conversion of Ypt1p-positive membranes to Ypt32p-positive membranes ([@B90]). Overexpression of Mon1-Ccz1 or GTPase-deficient Ypt7p inactivates the yeast Rab5 homolog, Vps21p ([@B87]). This suggests that a "counter-current" ([@B90]) of Rab inactivation does operate on late endosomes. However, no interaction between a Rab5/Vps21p GAP and Rab7/Ypt7p, or a Rab7/Ypt7p effector, has yet been found.

Termination of Mon1-Ccz1 action is mediated by post-translational modification. In yeast, the vacuolar casein kinase Yck3p phosphorylates Mon1p (**Figure [4](#F4){ref-type="fig"}**; [@B63]). Phosphorylated Mon1-Ccz1 then dissociates from vacuoles ([@B63]). Mon1-Ccz1 dissociates from lysosomes in mammalian cells, though it is not yet known how this dissociation is triggered ([@B131]).

Another possible mechanism for Mon1-Ccz1 inactivation is PI(3)P hydrolysis, which would weaken Mon1-Ccz1 membrane binding (**Figure [4](#F4){ref-type="fig"}**; [@B84]). Myotubularin phosphatases (MTMs) hydrolyze the 3-phosphate of PI(3)P on endosomes and autophagosomes ([@B9]; [@B111]; [@B114]; [@B124]). In *Drosophila*, MTM1 is required for lysosomal function ([@B114]). In *C. elegans*, MTM-3 is needed for autophagosome-lysosome fusion ([@B124]). These results suggest that PI(3)P hydrolysis and Mon1-Ccz1 release play a role in endosome maturation and autophagy.

Binding of Mon1-Ccz1 to LC3 proteins also promotes Mon1-Ccz1 function in autophagy. In yeast, Mon1-Ccz1 binds the LC3 protein Atg8p via LIR motifs in Ccz1 ([@B31]). This binding is needed for Mon1-Ccz1 association with autophagosomes. Mon1-Ccz1/Atg8p binding also activates the GEF activity of Mon1-Ccz1 activity for Ypt7p ([@B31]). Membrane recruitment may activate Mon1-Ccz1 by increasing its local concentration near membrane-associated Ypt7p, but allosteric activation upon Atg8p binding cannot be ruled out. Mon1-Ccz1 binding to metazoan LC3 proteins has not been observed, but the LIR motifs in Ccz1 are also found in mammals ([@B31]).

There are few direct connections between Mon1-Ccz1 and human disease, though autophagy is central to many aspects of human health, including cancer and neuronal/cardiac ischemia ([@B20]). However, Ccz1 is post-transcriptionally downregulated by miR-1, a microRNA that causes cardiac arrhythmias when overexpressed ([@B129]; [@B107]). This suggests that Mon1-Ccz1-dependent autophagy or mitophagy suppresses arrhythmias, perhaps by removing damaged mitochondria that generate aberrant intracellular ion fluxes in cardiomyocytes ([@B11]).

Summary
-------

The sole known Rab7/Ypt7p GEF, Mon1-Ccz1, is also a Rab5 effector ([@B59]). Mon1-Ccz1 thereby mediates Rab5-dependent recruitment of Rab7, a process termed "Rab conversion" (**Figure [4](#F4){ref-type="fig"}**; [@B89]). Binding of Mon1-Ccz1 to LC3 proteins also promotes Mon1-Ccz1 association with autophagosomes ([@B31]). PI(3)P binding is needed for Mon1-Ccz1 membrane association ([@B84]). Together, these interactions support Mon1-Ccz1 action in endocytic trafficking and autophagy. Mon1-Ccz1 release from membranes is triggered by its phosphorylation ([@B63]), and possibly by PI(3)P dephosphorylation ([@B124]), permitting Rab7 deactivation and GDI extraction.

Rab7 Gaps
=========

General Biochemical Mechanism of Rab GAP Action
-----------------------------------------------

Rab GAPs use the conserved Tre2/Bub2/Cdc16 (TBC) domain to activate GTP hydrolysis ([@B30]). **Figure [5](#F5){ref-type="fig"}** shows the mechanism by which a TBC domain (green) modulates the active site of a Rab GTPase (purple). This figure depicts a homology model ([@B120]) of Rab7 bound to the TBC domain of the Rab7 GAP Armus/TBC1D2A, and is based on the crystal structure of Rab33 bound to the Gyp1p TBC domain ([@B79]). A conserved glutamine from the GAP (Q713) activates a water molecule (blue) for hydrolysis. Meanwhile, a conserved arginine from the GAP (R676) provides positive charge to stabilize the GDP leaving group and the planar transition-state form of the γ phosphate, which is mimicked by an AlF~3~^-^ molecule ([@B79]).

![Mechanism of GTP hydrolysis by a Rab GAP. Purple, Rab7; green, Armus/TBC1D2A. The Rab7/Armus complex shown here is a homology model of human Rab7 bound to the TBC domain of human Armus, built using Swiss-Model and based on the crystal structure of Rab33 in complex with Gypl (PDB code 2G77). Figure was made using MacPyMOL.](fcell-06-00129-g005){#F5}

This "dual-finger mechanism" ([@B79]) differs from the mechanism of Ras GAPs, which use a single "arginine finger" to stabilize the transition state ([@B94]). This difference is important because in Ras GAP-mediated GTP hydrolysis, the hydrolyzing water is activated by a glutamine from the Ras GTPase itself ([@B94]). In Rab GTPases, the equivalent glutamine is not needed for GAP-mediated GTP hydrolysis, and is flipped away from the active site in the Rab-GAP complex (**Figure [5](#F5){ref-type="fig"}**, Q67, bottom left). As a result, Rab GAPs can stimulate GTP hydrolysis by mutant Rab GTPases lacking this glutamine, though the stimulated rate is lower than that of GAP-stimulated wild-type Rab proteins by up to an order of magnitude ([@B23]; [@B79]).

The conserved glutamine and arginine mentioned above account for most of the GTPase-activating function of Rab GAPs. However, there are at least 27 proteins containing TBC domains in the human genome, and roughly 70 Rab GTPases. There is no satisfactory method for predicting specificity from a TBC domain's sequence. Rather, researchers have determined TBC domains' specificity empirically, by testing them for GAP activity against panels of Rab GTPases ([@B45]; [@B79]; [@B29]).

Accessory domains in Rab GAPs (**Figure [6](#F6){ref-type="fig"}**) may determine Rab specificity by constraining Rab GAPs' cellular localization (**Figure [2](#F2){ref-type="fig"}**). No known Rab GAP consists of only a TBC domain. The domain architecture of Rab GAPs is diverse: they can contain lipid binding domains, coiled-coil motifs, LC3-interacting regions (LIRs), domains that bind to other small GTPases, and other domains with GAP and GEF activity ([@B30]). Some accessory domains may determine Rab GAP localization via interactions with phospholipids and other proteins (**Table [1](#T1){ref-type="table"}**). Thus, proximity of Rab GAPs to particular Rab GTPases, which themselves have distinct cellular localizations ([@B66]), may dictate which Rab GAPs act on which Rabs.

![Domain structure of Rab GAPs. PH, Phox homology domain; LIR, LC3-interacting region; CC, predicted coiled-coil; TBC: Tre-2/Bub2/Cdcl6 domain. Domain assignments were made using the Simple Modular Architecture Research Tool (SMART) server, <http://smart.embl-heidelberg.de/help/smart_about.shtml>.](fcell-06-00129-g006){#F6}

###### 

Rab7/Ypt7p GTPase activating proteins (GAPs).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Name                                         Cellular location                                Other interactions                                                                                                                                  Effect of overexpression                                      Effect of knockdown or
  -------------------------------------------- ------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------
  Armus/TBC1D2A/ TBC1D2/TBC-2 (*C. elegans*)   Plasma membrane/ cell-cell junctions ([@B28])\   E-cadherin ([@B28])\                                                                                                                                Reduction of EGF-induced cell scattering ([@B28])\            Autophagosome accumulation, reduction of starvation-induced LC3-II degradation ([@B19]; [@B113])\
                                               Late endosomes ([@B21]; [@B46])\                 Rac1 ([@B28])\                                                                                                                                                                                                    Endosome accumulation ([@B21])\
                                               Autophagosomes ([@B19])                          LC3A ([@B82]; [@B19]), GABARAP-L1 ([@B82])\                                                                                                                                                                       Impaired EGF, LDL, *trans*-ferrin uptake ([@B102])
                                                                                                Leucine-rich repeat kinase 1 (LRRK1) ([@B113])\                                                                                                                                                                   
                                                                                                PI(3)P, PI(4)P ([@B46]; [@B62])                                                                                                                                                                                   

  TBC1D2B                                      n.d.                                             LC3A ([@B82]), LC3B ([@B8]), LC3C ([@B8]), GABARAP ([@B8]), GABARAP-L1 ([@B8]; [@B82]), GABARAP-L2 ([@B8])                                          n.d.                                                          n.d.

  TBC1D5                                       Late endosomes ([@B100])\                        Retromer (via Vps29) ([@B100])\                                                                                                                     Reduced retromer-membrane association ([@B100])\              Reduced autophagosome formation ([@B82])\
                                               Autophagosomes ([@B82])                          LC3A ([@B82]; [@B93]), LC3C ([@B93]), GABARAP-L1 ([@B82])\                                                                                                                                                        Retromer cargo accumulation in endosomes ([@B49])\
                                                                                                Atg9 ([@B83])\                                                                                                                                                                                                    Enhanced retromer activity ([@B101])\
                                                                                                Ulk1 ([@B83])                                                                                                                                                                                                     

  TBC1D15                                      Mitochondria ([@B78]; [@B128])                   Fis1 ([@B78])\                                                                                                                                      Increased number of lysosomes per cell ([@B81])\              Elongated mitochondria ([@B78])\
                                                                                                LC3A ([@B128]), LC3B ([@B8]; [@B128]), LC3C ([@B8]; [@B128]), GABARAP ([@B8]; [@B128]), GABARAP-L1 ([@B8]; [@B128]), GABARAP-L2 ([@B8]; [@B128])\   Delayed cell death upon growth factor withdrawal ([@B81])\    LC3 accumulation during mitophagy ([@B128])\
                                                                                                TBC1D17 ([@B128])\                                                                                                                                  GAP-deficient mutants block mitochondrial fission ([@B123])   Reduced clearance of damaged mitochondria ([@B128])\
                                                                                                Vac14 ([@B97])\                                                                                                                                                                                                   Little effect on starvation-induced autophagy ([@B128])
                                                                                                Rab5 (but has no GAP activity for Rab5) ([@B45])                                                                                                                                                                  

  Gyp7p (yeast)                                Cytosol                                          None identified                                                                                                                                     Reduced vacuole fusion upon hypo-osmotic shock ([@B10])       Small decrease in vacuole fragmentation ([@B10])
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Armus/TBC1D2A
-------------

The first Rab7-specific GAP to be described, Armus/TBC1D2A, was discovered via a two-hybrid screen for effectors of the Rac1 GTPase ([@B28]). In this study, Armus was found to regulate cell-cell adhesion and E-cadherin degradation ([@B28]). Overexpression of a construct containing the Armus TBC domain and carboxy-terminal coiled-coil motif (**Figure [6](#F6){ref-type="fig"}**) -- which localizes to the plasma membrane at cell-cell junctions (**Figure [2](#F2){ref-type="fig"}**) -- blocks endocytosis and degradation of the cell adhesion molecule E-cadherin ([@B28]). This construct also stabilizes cell-cell contacts in keratinocytes ([@B28]). This stabilization may be caused by reduction in active Rab7 and a concomitant reduction in transport to the lysosome via the endocytic pathway.

Counterintuitively, siRNA-mediated knockdown of Armus expression also stabilizes cell-cell junctions ([@B28]). Likely this is because GDI delivers Rab7 to maturing endosomes, as described above (**Figure [4](#F4){ref-type="fig"}**; [@B84]). GDI binds and extracts only GDP-bound Rab proteins from membranes ([@B2]; [@B33]). Thus, if Rab7 GTP hydrolysis is reduced via Armus knockdown, formation of the soluble Rab7-GDI complex and Rab7 delivery to endosomes also will be reduced. As evidence for the importance of GTP hydrolysis for proper Rab7 localization, knockout of another Rab7 GAP, TBC1D5, redistributes Rab7 from late endosomes to lysosomes ([@B51]). Additionally, a GTPase-deficient mutant of the yeast exocytic Rab Sec4p (Q79L) is a cold-sensitive loss-of-function allele that causes accumulation of secretory vesicles and reduced secretion ([@B116]).

Armus also acts in autophagy ([@B19]). When Armus is overexpressed, enlarged autophagosomes accumulate, whereas reduction of Armus expression blocks autophagic flux ([@B19]). Supporting its role in autophagy, Armus binds the autophagosomal protein LC3 ([@B19]). Armus does this via two LC3-interacting regions (LIRs), one just after its amino-terminal pleckstrin homology (PH) domain and the second near its carboxy terminus (**Figure [6](#F6){ref-type="fig"}**; [@B19]). This study examined Armus binding to one of the six human LC3 proteins, LC3A ([@B19]), but other work has shown that Armus binds both LC3A and GABARAP-L1 ([@B82]). Thus, Armus appears to link the action of Rac1 and Rab7 during autophagy. Rac1-GTP is reduced in starvation-induced autophagy ([@B19]). This suggests that decreased Rac1-GTP causes decreased Armus recruitment, which then would boost Rab7-GTP levels and promote autophagosome-lysosome fusion.

How does the Armus PH domain (**Figure [6](#F6){ref-type="fig"}**) affect Armus function? Knockdown in cultured mammalian cells of Vps34/PI3KC3, the kinase that phosphorylates PI (phosphatidylinositol) to PI(3)P (phosphatidylinositol-3-phosphate) on endosomes, blocks Armus recruitment to membranes ([@B46]). Vps34/PI3KC3 knockdown also causes increased Rab7-GTP levels, enlarged late endosomes, and impaired lysosomal cargo delivery ([@B46]). The Armus PH domain binds PI(3)P and PI(4)P in lipid overlay and liposome floatation assays ([@B46]; [@B62]). Thus, the PH domain of Armus likely helps recruit it to endosomal membranes by binding PI(3)P.

The *C. elegans* Armus homolog, TBC-2, has *in vitro* GAP activity not only for Rab7 (i.e., RAB-7), but also Rab5 (i.e., RAB-5), which governs trafficking to early endosomes ([@B21]). However, this does not necessarily conflict with the role of mammalian Armus in inactivating Rab7. First, this study used only the TBC domain of *C. elegans* TBC-2, which, as discussed above, might not contain all of the determinants for Rab specificity ([@B21]). Second, even if both mammalian Armus and *C. elegans* TBC-2 have dual specificity for Rab5 and Rab7, this might be an elegant method of inactivating Rab5 on late endosomes, i.e., a proofreading or mop-up function. Finally, Armus and TBC-2 simply may have different functions in their respective organisms.

The Roco kinase leucine-rich repeat kinase 1 (LRRK1) also regulates Armus activity ([@B113]). Autophagosome-lysosome fusion is impaired in LRRK^-/-^ knockout cells ([@B113]). Rab7-GTP levels also are elevated, and are further elevated during autophagy ([@B113]). LRRK1 phosphorylation blocks an intramolecular interaction between the PH and TBC domains of Armus, though neither the binding interface nor the site of phosphorylation has yet been identified ([@B113]). Thus, phosphorylation of Armus by LRRK1 may relieve an autoinhibitory interaction between its PH and TBC domains, permitting PI(3)P binding, GAP activity, or both. Interaction with another protein, perhaps via the coiled-coil domain of Armus (**Figure [6](#F6){ref-type="fig"}**), that modulates Armus membrane recruitment and/or activity also cannot be ruled out. LRRK1 is closely related to LRRK2, which is mutated in familial Parkinson's disease ([@B139]). LRRK2 has not been shown to phosphorylate Armus. Nevertheless, cycling of Rab7 between membrane and cytosol -- which requires GTP hydrolysis by Rab7 ([@B2]; [@B33]) -- is decreased in cells with Parkinson's disease-linked LRRK2 mutations ([@B35]).

Armus has other links to human disease. An Armus variant termed PARIS-1 was found in a screen for antigens recognized by sera from prostate cancer patients ([@B138]). PARIS-1 is identical to Armus, except for a deletion of 11 amino acids in its TBC domain (residues 819--829). The biochemical effect of this deletion is not obvious: PARIS-1 is stably expressed ([@B138]), and in the crystal structure of the Rab33-Gyp1p TBC domain complex used to make **Figure [5](#F5){ref-type="fig"}**, these residues do not directly contact the Rab ([@B79]). Perhaps these residues stabilize structural elements that are important for GAP activity. In another link between Armus and cancer, Armus expression is inhibited by a microRNA (miRNA) from a cluster of six miRNAs, miR-17-92/oncomir-1 ([@B102]), that is overexpressed or deleted in many cancers ([@B41]; [@B135]). Finally, a genome-wide association study of multiple sclerosis (MS) patients found an association with a single nucleotide polymorphism in an intron from the gene encoding Armus ([@B5]). This finding has been replicated in a follow-up study of a different group of MS patients ([@B95]). However, the basis for this linkage remains unknown.

TBC1D2B
-------

This protein is not a splice variant of Armus, i.e., TBC1D2 or TBC1D2A (**Table [1](#T1){ref-type="table"}**), but rather is encoded by a different gene, with 63% protein sequence identity and a virtually identical domain structure (**Figure [6](#F6){ref-type="fig"}**; [@B65]; [@B103]). However, the Rab specificity of TBC1D2B is unknown. It has been included in this review because of its similarity to Armus.

TBC1D2B also binds LC3 proteins. A proteomic study of the six human LC3 proteins found that TBC1D2B associates with five: LC3B, LC3C, GABARAP, GABARAP-L1, and GABARAP-L2 (**Table [1](#T1){ref-type="table"}**; [@B8]). A low-throughput study of TBC domain protein association showed that TBC1D2B also associates with LC3A (**Table [1](#T1){ref-type="table"}**; [@B82]). How TBC1D2B binds LC3 proteins is unknown, but the LIRs in Armus (residues 142--146 and 542--546; [@B19]) are also present in TBC1D2B (**Figure [6](#F6){ref-type="fig"}**).

TBC1D5
------

TBC1D5 was first identified as a retromer-binding protein ([@B100]). As described in the Introduction, retromer regulates protein sorting in the endocytic pathway ([@B67]). Retromer is needed for endosome-to-TGN retrieval of CI-MPR, which ferries hydrolytic enzymes to lysosomes ([@B3]). Retromer also mediates recycling of cell-surface receptors, e.g., β2AR and TβRII, from endosomes to the plasma membrane ([@B112]; [@B132]).

Retromer is a five-subunit complex consisting of two subcomplexes: a cargo-binding trimer of Vps26, Vps29, and Vps35, and a membrane-binding dimer of sorting nexins ([@B67]). The exact set of sorting nexins that bind Vps26/29/35 is variable ([@B67]). Differences in sorting nexin composition affect cargo selection and the trafficking pathway in which any particular retromer complex acts ([@B67]). Retromer is a Rab7 and Ypt7p effector and is recruited to membranes by binding to Rab7/Ypt7p ([@B91]; [@B100]) and through direct membrane binding by phox homology (PX) and bin/amphiphysin/Rvs (BAR) domains in the sorting nexins ([@B126]; [@B18]).

TBC1D5 binds retromer via Vps29 ([@B49]). This interaction may promote retromer function: shRNA-mediated knockdown of TBC1D5 expression reduces CI-MPR retrieval to the TGN ([@B82]). TBC1D5 knockdown also may suppress retromer function indirectly, by affecting Rab7 activation and/or localization: CRISPR-mediated TBC1D5 knockout markedly increases Rab7 co-localization with the lysosomal marker LAMP2 ([@B51]).

It should be mentioned that the TBC1D5's effect on retromer activity is not yet settled: a recent report suggests that TBC1D5 knockdown in fact boosts retromer activity ([@B101]). This discrepancy may be due to the degree of TBC1D5 knockdown. Complete TBC1D5 knockout forces Rab7 onto lysosomes, where it cannot bind and activate the retromer ([@B51]). In contrast, incomplete TBC1D5 knockdown may allow enough Rab7 on late endosomes/MVB's to support retromer activity -- and the reduction in TBC1D5 expression may in fact boost the amount of active Rab7.

Like Armus, TBC1D5 co-localizes with LC3 and plays a role in autophagy ([@B82]). TBC1D5 also is needed for mitophagy ([@B51]), a specialized form of autophagy that delivers mitochondria to lysosomes for destruction ([@B54]). TBC1D5 contains two LIR motifs (**Figure [6](#F6){ref-type="fig"}**), and both are required for co-localization with LC3 ([@B82]). However, the specific role of TBC1D5 in autophagy differs from that of Armus. Knockdown of TBC1D5 expression by shRNAs prevents accumulation of punctate LC3-positive structures, i.e., autophagosomes ([@B82]). Bafilomycin treatment, which blocks autophagosome-lysosome fusion ([@B127]), does not cause autophagosome buildup in TBC1D5-depleted cells ([@B82]). Thus, the defect in TBC1D5-depleted cells lies in autophagosome formation, not consumption. In agreement with this finding, TBC1D5 also interacts with Atg9 and Ulk1, an integral membrane protein and a kinase, respectively, that initiate autophagosome biogenesis ([@B133]; [@B134]; [@B83]).

How do these dual binding specificities, to LC3 proteins and the retromer, relate to one another? Experiments using purified proteins show that LC3A competes with the retromer subunit Vps29 for TBC1D5 binding ([@B82]). In agreement with this result, TBC1D5 co-localizes with Vps35 and LC3B, but Vps35 and LC3B do not themselves co-localize ([@B82]). Accordingly, the amino-terminal LIR motif in TBC1D5 is needed for retromer-TBC1D5 binding ([@B82]). Autophagy triggers the switch between these alternate binding modes: upon starvation, TBC1D5-LC3A co-localization is sharply increased, whereas TBC1D5-retromer binding becomes nearly undetectable ([@B93]). This effect is autophagy-dependent and not merely triggered by starvation, which does not block TBC1D5-retromer binding in cells lacking the autophagy regulator Atg7 ([@B93]). Retromer-mediated recycling of the GLUT1 glucose transporter from endosomes to the plasma membrane is increased during starvation ([@B93]). This effect might be caused by TBC1D5-LC3A binding during autophagy ([@B93]), which sequesters TBC1D5 and permits Rab7 activation in the vicinity of the retromer.

TBC1D15
-------

This Rab7 GAP is localized to mitochondria (**Figure [2](#F2){ref-type="fig"}**) and is involved primarily in mitochondrial physiology ([@B78]). TBC1D15 binds the mitochondrial fission regulator Fis1, and TBC1D15's mitochondrial localization is dependent on Fis1 ([@B78]). When TBC1D15 or Fis1 is knocked out, autophagosomes accumulate during valinomycin-induced mitophagy ([@B128]). Correspondingly, mitophagy is reduced when TBC1D15 or Fis1 is knocked out ([@B128]). In contrast, TBC1D15 knockout has little effect on starvation-induced autophagy ([@B128]). TBC1D15 differs from TBC1D5 in this respect: TBC1D5 is needed both for mitophagy ([@B51]) and bulk autophagy ([@B82]). TBC1D15 also interacts with LC3 proteins, as shown both by pulldown with GST-tagged LC3 proteins and using proteomic methods ([@B8]; [@B128]). A LIR motif responsible for this binding was found in TBC1D15 using mutagenesis (**Figure [6](#F6){ref-type="fig"}**; [@B128]).

These results have led to a model in which TBC1D15's interactions with Fis1 and LC3 proteins hold it in proximity to both mitochondria and autophagosomes ([@B128]). In this model, TBC1D15 supports formation of autophagosomes around damaged mitochondria ([@B128]). In the absence of TBC1D15, an excess of Rab7-GTP in apposition to mitochondria causes autophagosomes to grow larger than usual. The mechanism by which Rab7-GTP promotes autophagosome expansion is unknown. However, Rab7 knockdown in TBC1D15^-/-^ cells suppresses autophagosome expansion around mitochondria, suggesting that Rab7 indeed plays a role in this process ([@B128]).

TBC1D15 also regulates mitochondrion-lysosome contacts that are not involved in mitophagy ([@B123]). These contacts are dynamic, and TBC1D15-stimulated Rab7 GTP hydrolysis is required for their termination ([@B123]). Mitochondrial fission occurs at these lysosomal contact sites ([@B123]). Expression of GTPase-deficient Rab7 mutants or GAP-deficient TBC1D15 mutants sharply reduces mitochondrial fission at lysosomal contacts and causes mitochondrial elongation ([@B123]). Thus, TBC1D15-stimulated Rab7 GTP hydrolysis regulates mitochondrial morphology even when mitophagy is not induced ([@B123]). Expression of a Fis1 mutant that cannot bind TBC1D15 also blocks mitochondrial fission at lysosomal contacts, suggesting that Fis1 mediates TBC1D15 recruitment even in the absence of mitophagy ([@B123]).

Additional interactions link TBC1D15 to other aspects of membrane trafficking. Proteomic approaches identified an interaction between TBC1D15 and Vac14, a scaffolding protein that stimulates PIKfyve, the kinase that generates PI(3,5)P~2~ from PI(3)P ([@B97]). PI(3,5)P~2~ is essential for proper lysosomal pH and ion homeostasis ([@B40]). The significance of the TBC1D15-Vac14 interaction is unknown, but may be a mechanism by which PI(3,5)P~2~ generation is coordinated with Rab7 inactivation on lysosomes. TBC1D15 also interacts with the early endosomal Rab GTPase Rab5 ([@B45]). However, TBCD15 does not appear to have GAP activity toward Rab5 ([@B45]). Perhaps Rab5-TBC1D15 binding recruits a small amount of TBC1D15 to early endosomes, preventing Rab7 activation there. Finally, TBC1D15 interacts with the Rab GAP TBC1D17 ([@B128]), though neither the target of TBC1D17 nor the role of the TBC1D15-TBC1D17 interaction has been determined.

Gyp7p
-----

Gyp7p is the GAP for Ypt7p, the yeast vacuolar Rab GTPase ([@B115]; [@B10]). Deletion of the gene encoding Gyp7p has little effect on cell growth or vacuole morphology, other than a small increase in vacuole size ([@B10]). This is probably due to increased homotypic vacuole-vacuole fusion, a process that requires Ypt7p ([@B38]). Gyp7p overexpression does, however, cause vacuole fragmentation ([@B10]). Gyp7p overexpression also blocks vacuole fusion upon hypo-osmotic shock ([@B10]). Deletion of the gene for Gyp7p does not affect autophagy, though autophagy is known to require Ypt7p ([@B125]).

Little is known about the domain structure of Gyp7p, other than the presence of a TBC domain (**Figure [6](#F6){ref-type="fig"}**). Overall, the positioning of Gyp7p's TBC domain is similar to that of TBC1D15, toward the carboxy terminus of the protein (**Figure [6](#F6){ref-type="fig"}**). No conserved domains have been identified in the amino-terminal regions of either TBC1D15 or Gyp7p, except for TBC1D15's LIR motif ([@B128]). This motif may be conserved in Gyp7p: the sequence of TBC1D15's LIR, from residues 280--283, is FEVI, whereas Gyp7p contains a sequence of FNDL in roughly the same region, from residues 329--332. The core LIR consensus sequence is \[WFY\]xx\[ILV\], though neighboring residues can affect LC3 family protein binding ([@B47]). However, Gyp7p has no known role in autophagy and is not known to bind Atg8p, the yeast LC3 protein, nor is there any known effect of mutating these residues.

Summary
-------

The Rab7 GAPs have diverse cellular roles (**Table [1](#T1){ref-type="table"}**). Armus/TBC1D2A is needed for endocytosis of cell adhesion molecules and modulation of cell-cell contacts ([@B28]). Armus also interacts with LC3 family proteins and mediates fusion of starvation-induced autophagosomes with lysosomes ([@B82]; [@B19]). TBC1D5 interacts with the retromer complex, a Rab7 effector, and regulates retromer's associations with membranes ([@B100]). TBC1D5 also interacts with LC3 proteins, though it regulates autophagosome nucleation and expansion, i.e., earlier stages of autophagy than those regulated by Armus ([@B82]; [@B93]). TBC1D15 also regulates autophagosome expansion, but in the context of mitophagy, rather than starvation-induced autophagy ([@B128]). Like Armus and TBC1D5, TBC1D15 binds LC3 family proteins ([@B8]; [@B128]). TBC1D15 also binds the outer mitochondrial membrane protein Fis1, which may explain its ability to promote assembly of autophagosomes around damaged mitochondria ([@B78]). In addition, TBC1D15 regulates dynamic lysosome-mitochondrion contacts that mark the sites of mitochondrial fission ([@B123]). Finally, Gyp7p is the GAP for the yeast Rab7 homolog Ypt7p ([@B115]; [@B10]). Little is known about Gyp7p, perhaps because phenotypes for its deletion or overexpression are fairly weak ([@B10]). No interactors for Gyp7p, other than Ypt7p, have been identified, nor does Gyp7p have any known role in autophagy.

Bacterial Effectors/Virulence Factors That Modulate Rab7 Nucleotide Binding
===========================================================================

Bacterial pathogens manipulate host intracellular trafficking in order to establish comfortable intracellular niches ([@B121]). This is accomplished by secreted bacterial proteins termed virulence factors or effectors ([@B1]). These effectors allow bacterial cells, engulfed via phagocytosis, to replicate inside host cells. Rab GTPases, including Rab7, are common targets of bacterial effector proteins ([@B105]). Two bacterial effectors manipulate the nucleotide-binding state of Rab7: RidL from *Legionella pneumophila*, and SopD2 from *Salmonella enterica* (serovar Typhimurium).

RidL is secreted by *L. pneumophila*, which causes Legionnaires' Disease ([@B27]). RidL is a substrate for the *Legionella* type IV secretion system (T4SS), which secretes bacterial proteins into host cell cytosol, across the bacterial inner and outer membranes and the limiting membrane of the *Legionella*-containing vacuole (LCV) that contains intracellular *Legionella* ([@B4]). After secretion, RidL localizes to endosomes, where it binds the retromer via Vps29 (**Figure [7A](#F7){ref-type="fig"}**; [@B27]). This interaction competitively blocks TBC1D5-Vps29 binding and displaces TBC1D5 into the cytosol ([@B6]; [@B130]). RidL does not displace Rab7 from LCVs; thus, Rab7 remains GTP-bound in the presence of RidL (**Figure [7A](#F7){ref-type="fig"}**; [@B6]). How RidL promotes *Legionella* survival and replication remains unclear. Perhaps the LCV acts as a sink for Rab7-GTP, reducing Rab7 levels on late endosomes and blocking transport of lysosomal hydrolases from late endosomes to LCVs.

![Bacterial effectors that modulate Rab7 nucleotide binding. **(A)** Mechanism of *Legionella* RidL: displacement of TBC1D5 from the Retromer complex and away from Rab7-GTR. Purple, Rab7-GTP; black, RidL; blue, TBC1D5; orange, Vps35; green, Vps29; yellow, Vps26; pink and red, sorting nexins. White asterisks denote binding sites in RidL and TBC1D5 for Vps29. **(B)** Mechanism of *Salmonella* SopD: binding Rab7-GDP and preventing Monl-Cczl GEF action. Purple, Rab7-GDP; black, SopD; green, Monl; blue, Cczl.](fcell-06-00129-g007){#F7}

The *S. enterica* (serovar Typhimurium) effector SopD2 directly blocks Rab7 nucleotide exchange ([@B22]). SopD2 is secreted via the syringe-like type III secretion system (T3SS) ([@B85]), which pierces the host cell membrane surrounding the *Salmonella*-containing vacuole (SCV) where intracellular Salmonella reside ([@B72]). SopD2 then blocks endocytic trafficking to lysosomes ([@B22]). SopD2 does this by preventing association of certain Rab7 effectors, in particular RILP and FYCO, which govern endosome, lysosome, and autophagosome mobility ([@B17]; [@B53]; [@B52]; [@B80]; [@B77]), from the SCV ([@B22]). The precise molecular mechanism of SopD2 action has not yet been determined. However, purified SopD2 slows nucleotide exchange on purified Rab7, i.e., with no GEF present ([@B22]). This suggests that SopD2 binds and stabilizes Rab7-GDP (**Figure [7B](#F7){ref-type="fig"}**). This, in turn, would prevent Mon1-Ccz1 from catalyzing nucleotide exchange on Rab7-GDP and promoting delivery of hydrolytic enzymes to the SCV.

Summary
-------

Two known bacterial effectors modulate the nucleotide-binding state of Rab7. *Legionella* RidL displaces TBC1D5 from the retromer and thus probably locks Rab7 in its GTP-bound form. *Salmonella* SopD binds directly to GDP-bound Rab7 and blocks nucleotide exchange, i.e., activation. It is likely that more examples of the manipulation of Rab7 nucleotide binding by bacterial effectors will be found. Individual *Legionella* strains each secrete an estimated 300 proteins via the T4SS ([@B96]). Between the many *Legionella* strains that have been isolated, roughly 600 distinct T4SS substrates have been identified, and of these only 7 are conserved among all strains ([@B12]). The repertoire of the Salmonella T3SS is more limited, with just 30 known substrates, but only about half of these have known functions ([@B26]).

Conclusion and Outlook
======================

Rab7 and Ypt7p govern both endolysosomal trafficking and autophagy ([@B37]). They accomplish this by binding to a large and diverse set of effectors ([@B99]; [@B125]; [@B17]; [@B53]; [@B64]; [@B80]; [@B108]). But before this can happen, the nucleotide-binding state of Rab7 and Ypt7p must be controlled in both time and space by the GEF and GAPs discussed here. Much work has gone into discovering these factors and elucidating their protein-protein and protein-lipid interactions (**Figures [4](#F4){ref-type="fig"}, [6](#F6){ref-type="fig"} and Table [1](#T1){ref-type="table"}**). These studies have made it possible to now seek a deeper level of understanding: How do Rab7/Ypt7p's GEF and GAPs specify Rab7/Ypt7p activation at particular places and times?

Specific questions include, but are not limited to: Since Rab5 has many effectors besides Mon1-Ccz1 ([@B118]), how is Mon1-Ccz1 recruitment by Rab5 triggered (**Figure [4](#F4){ref-type="fig"}**; [@B59])? What determines when Mon1-Ccz1 is deactivated by phosphorylation ([@B63]) and PI(3)P hydrolysis ([@B114]; [@B124])? What is the functional significance of the binding of Rab7 GAPs to different LC3 proteins (**Table [1](#T1){ref-type="table"}**)? What regulates LRRK1 phosphorylation of Armus/TBC1D2 ([@B113]), and what triggers dephosphorylation? Does cargo binding to the retromer affect TBC1D5-retromer binding ([@B100]), and vice versa? What mediates the switch between retromer and LC3 binding by TBC1D5 during autophagy ([@B93])? Given that Armus and TBC1D5 both bind LC3 proteins ([@B82]; [@B19]; [@B93]), why does Armus mediate autophagosome-lysosome fusion ([@B19]) and TBC1D5 regulate autophagosome formation ([@B82])? How does TBC1D15 shift from regulating mitochondrion-lysosome contacts ([@B123]) to regulating autophagosome growth around mitochondria ([@B128])?

Answers to these questions may come from an improved understanding of how the intermolecular interactions of Rab GEFs and GAPs change in time and space, and how they are affected by cellular metabolic state and the physical and chemical growth environment. Methods that could prove useful include FRET-based and split-enzyme/split-fluorescent protein biosensors for protein-protein interactions ([@B55]), proximity ligation and proteomics for unbiased sampling of protein-protein binding ([@B69]), and ion mobility mass spectrometry for isolating and characterizing protein-lipid complexes from native environments ([@B68]). Such approaches will allow development of quantitative, integrated models that explain how Rab7 nucleotide binding is regulated and, in turn, regulates endolysosomal trafficking and autophagy.
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